You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 5, 2024

ETOPOSIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Etoposide, and what generic alternatives are available?

Etoposide is a drug marketed by Mylan, Accord Hlthcare, Dash Pharms, Dash Pharms Natco, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, and Watson Labs Inc. and is included in fifteen NDAs.

The generic ingredient in ETOPOSIDE is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Etoposide

A generic version of ETOPOSIDE was approved as etoposide by HIKMA on July 17th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ETOPOSIDE?
  • What are the global sales for ETOPOSIDE?
  • What is Average Wholesale Price for ETOPOSIDE?
Drug patent expirations by year for ETOPOSIDE
Drug Prices for ETOPOSIDE

See drug prices for ETOPOSIDE

Recent Clinical Trials for ETOPOSIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Genentech, Inc.Phase 1/Phase 2
Vanderbilt-Ingram Cancer CenterPhase 1/Phase 2
Vanderbilt-Ingram Cancer CenterPhase 2

See all ETOPOSIDE clinical trials

Pharmacology for ETOPOSIDE
Drug ClassTopoisomerase Inhibitor
Mechanism of ActionTopoisomerase Inhibitors
Medical Subject Heading (MeSH) Categories for ETOPOSIDE

US Patents and Regulatory Information for ETOPOSIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan ETOPOSIDE etoposide CAPSULE;ORAL 075635-001 Sep 19, 2001 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira ETOPOSIDE etoposide INJECTABLE;INJECTION 074320-001 Aug 30, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dash Pharms Natco ETOPOSIDE etoposide INJECTABLE;INJECTION 203507-001 Nov 20, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Parenteral ETOPOSIDE etoposide INJECTABLE;INJECTION 074510-001 Jun 29, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira ETOPOSIDE etoposide INJECTABLE;INJECTION 074351-001 Aug 30, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.